Clinical Trials on Rubulavirus Infections

Total 56546 results

Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old

Mumps

China
Jiangsu Province Centers for Disease Control and...

Completed

Observational Study to Assess Protection to Mumps in Children Received One-dose Mumps-containing Vaccine

Fever | Parotid Gland Infection

China
Institute of Medical Biology, Chinese Academy of...
Hebei Provincial Center for Diseases Control and Prevention

Completed

A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

Mumps

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

Mumps

China
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Active, not recruiting

Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11

Epidemic Parotitis, Mumps

China
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
GlaxoSmithKline

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Measles | Rubella | Mumps | Varicella

Germany, Italy, France
GlaxoSmithKline

Active, not recruiting

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles; Mumps; Rubella; Chickenpox

United States, Taiwan, Spain, Argentina, Turkey, Colombia, Puerto Rico, Latvia, Chile
Sri Edupuganti, MD MPH
Merck Sharp & Dohme LLC

Completed

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Measles | Rubella | Mumps

United States
GlaxoSmithKline
Parexel

Completed

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Measles | Rubella | Mumps

United States, Slovakia, Estonia
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations (MMR)

Measles | Rubella | Mumps

Brazil
Merck Sharp & Dohme LLC

Completed

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Zhejiang Provincial Center for Disease Control...

Active, not recruiting

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Measles | Rubella | Mumps | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18

China
Merck Sharp & Dohme LLC

Completed

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Measles | Rubella | Mumps | Varicella

Canada, Italy
GlaxoSmithKline

Withdrawn

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Measles | Rubella | Mumps | Varicella
The Immunobiological Technology Institute (Bio-Manguinhos)...
GlaxoSmithKline

Completed

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Measles | Rubella | Mumps | Varicella

Brazil
University of Michigan

Completed

Making Decisions About the Measles-Mumps-Rubella Vaccine

Measles | Rubella | Mumps | MMR Vaccination

United States
University of Zurich
Merck Sharp & Dohme LLC

Recruiting

Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination (MIPS)

Measles | Rubella | Mumps

Switzerland
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)

Measles | Rubella | Mumps

Brazil
Institute of Medical Biology, Chinese Academy of...
Hubei Provincial Center for Disease Control and Prevention

Active, not recruiting

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Epidemic Parotitis,Mumps

China
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Measles | Rubella | Mumps | Varicella
GlaxoSmithKline

Completed

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Measles | Rubella | Mumps | Varicella

India
GlaxoSmithKline

Completed

Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

Measles | Rubella | Mumps | Varicella

Korea, Republic of
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Belgium, Germany, Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Measles | Rubella | Mumps | Varicella

Finland, Germany, Poland, Greece
GlaxoSmithKline

Completed

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Measles | Rubella | Mumps | Varicella

Germany, Austria
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
Sinovac Biotech Co., Ltd

Active, not recruiting

The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students

Mumps | Influenza

China
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Measles-Mumps-Rubella

Taiwan, United States, Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine

Measles | Hepatitis A | Rubella | Mumps

Turkey
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Japanese Encephalitis | Measles | Rubella | Mumps

Taiwan
PATH
Syneos Health; Research Institute for Tropical Medicine; DF/Net Research, Inc.

Completed

Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine

Encephalitis, Japanese | Measles | Rubella | Mumps

Philippines
Liaoning Chengda Biotechnology CO., LTD

Recruiting

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Japanese Encephalitis | Measles | Rubella | Mumps

China
Kirby Institute

Not yet recruiting

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised. (PATH)

Invasive Fungal Infections | Infection, Bacterial | Infection, Fungal | Injection Site Infection | Infection, Soft Tissue | Invasive Bacterial Infection
Pfizer

Completed

Post-Authorization Study Evaluating Safety Of Tigecycline (HORUS)

Intra-Abdominal Infections | Skin Disease, Infectious | Soft Tissues Infections
Johns Hopkins Bloomberg School of Public Health

Completed

Etiology, Prevention and Treatment of Neonatal Infections in the Community

Infectious Disease | Bacterial Infection

Bangladesh
Mayo Clinic
Ortho-McNeil, Inc.

Completed

The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

Staphylococcal Infection | Staphylococcus Aureus Prosthetic Joint Infection

United States
University Hospital, Strasbourg, France

Recruiting

Infections With Enterobacteria Producing Carbapenemases at the University Hospitals of Strasbourg (CARBA)

Nfections, Enterobacterial

France
Hospices Civils de Lyon

Completed

Staphylococcus Lugdunensis Prosthetic Joint Infection

Staphylococcal Infections | Prosthetic Joint Infection

France
Adaptive Phage Therapeutics, Inc.

Withdrawn

Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections (ACTIVE1)

Bacterial Infections | Prosthetic Joint Infection
Orlando Health, Inc.
Forest Laboratories

Withdrawn

Ceftaroline in the Treatment of Bone and Joint Infections

Osteomyelitis | Joint Infections

United States
University Hospital, Strasbourg, France

Unknown

Cliavist in Infectious and Degenerative Diseases of the Spine

Spine Infection

France
Hospices Civils de Lyon

Completed

Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection

Bacterial Infections | Bone and Joint Infection | EPIDEMIOLOGY
University Hospital, Brest
Centre de Référence des Infections Ostéo-Articulaires du Grand Ouest

Completed

Retrospective Study of Bone Infection Due to Campylobacter Spp (CAMPYLO)

Bone Diseases, Infectious | Campylobacter Infections

France
Hospices Civils de Lyon

Completed

Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration

Staphylococcus Aureus | Bone and Joint Infection | Teicoplanin-based Antimicrobial Therapy

France

3

Subscribe